Overview and transparency of non-research payments to healthcare organizations and healthcare professionals from pharmaceutical companies in Japan: Analysis of payment data in 2016
Author
Abstract
Suggested Citation
DOI: 10.1016/j.healthpol.2020.03.011
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
References listed on IDEAS
- Roy H Perlis & Clifford S Perlis, 2016. "Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs," PLOS ONE, Public Library of Science, vol. 11(5), pages 1-12, May.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Moriarty, Frank & Larkin, James & Fahey, Tom, 2021. "Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational study," Health Policy, Elsevier, vol. 125(10), pages 1297-1304.
- Mulinari, Shai & Martinon, Luc & Jachiet, Pierre-Alain & Ozieranski, Piotr, 2021. "Pharmaceutical industry self-regulation and non-transparency: country and company level analysis of payments to healthcare professionals in seven European countries," Health Policy, Elsevier, vol. 125(7), pages 915-922.
- Anju Murayama & Yuki Senoo & Kayo Harada & Yasuhiro Kotera & Hiroaki Saito & Toyoaki Sawano & Yosuke Suzuki & Tetsuya Tanimoto & Akihiko Ozaki, 2022. "Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians," IJERPH, MDPI, vol. 19(6), pages 1-24, March.
- Harada, Kayo & Ozaki, Akihiko & Saito, Hiroaki & Sawano, Toyoaki & Yamamoto, Kana & Murayama, Anju & Senoo, Yuki & Tanimoto, Tetsuya, 2021. "Financial payments made by pharmaceutical companies to the authors of Japanese hematology clinical practice guidelines between 2016 and 2017," Health Policy, Elsevier, vol. 125(3), pages 320-326.
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Susan F Wood & Joanna Podrasky & Meghan A McMonagle & Janani Raveendran & Tyler Bysshe & Alycia Hogenmiller & Adriane Fugh-Berman, 2017. "Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia," PLOS ONE, Public Library of Science, vol. 12(10), pages 1-13, October.
- Thomas Lebesmuehlbacher & Rhet A. Smith, 2021. "The effect of medical cannabis laws on pharmaceutical marketing to physicians," Health Economics, John Wiley & Sons, Ltd., vol. 30(10), pages 2409-2436, September.
- Ansari, Bahareh, 2021. "Industry payments and physicians prescriptions: Effect of a payment restriction policy," Social Science & Medicine, Elsevier, vol. 278(C).
- Waqas Haque & Abu Minhajuddin & Arjun Gupta & Deepak Agrawal, 2018. "Conflicts of interest of editors of medical journals," PLOS ONE, Public Library of Science, vol. 13(5), pages 1-12, May.
- Anju Murayama & Sae Kamamoto & Hiroaki Saito & Kohki Yamada & Divya Bhandari & Iori Shoji & Hanano Mamada & Moe Kawashima & Erika Yamashita & Eiji Kusumi & Toyoaki Sawano & Binaya Sapkota & Tetsuya Ta, 2022. "Pharmaceutical Payments to Japanese Board-Certified Infectious Disease Specialists: A Four-Year Retrospective Analysis of Payments from 92 Pharmaceutical Companies between 2016 and 2019," IJERPH, MDPI, vol. 19(12), pages 1-13, June.
- Toon van der Gronde & Carin A Uyl-de Groot & Toine Pieters, 2017. "Addressing the challenge of high-priced prescription drugs in the era of precision medicine: A systematic review of drug life cycles, therapeutic drug markets and regulatory frameworks," PLOS ONE, Public Library of Science, vol. 12(8), pages 1-34, August.
More about this item
Keywords
Drug industry; Professional autonomy; Conflicts of interest; Japan;All these keywords.
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:eee:hepoli:v:124:y:2020:i:7:p:727-735. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Catherine Liu or the person in charge (email available below). General contact details of provider: http://www.elsevier.com/locate/healthpol .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.